Table 4.
Management Approach for a Patient with Confirmed NASH via Liver Biopsy
| PCP (n = 221) | Hepatology (n = 48) | Gastroenterology (n = 126) | Endocrinology (n = 83) | |
|---|---|---|---|---|
| How likely are you to recommend each of the following initially?* | ||||
| Drug therapy for diabetes control | 4.3 | 4.1 | 4.1 | 4.6 |
| Drug therapy for dyslipidemia | 4.2 | 4.1 | 4.0 | 4.4 |
| Drug therapy for NASH | 2.6 | 2.8 | 2.4 | 2.9 |
| Drug therapy for weight loss | 2.3 | 2.4 | 2.0 | 3.4 |
| Bariatric surgery | 2.2 | 2.4 | 2.3 | 2.7 |
| How likely are you to recommend each of the following 12 months of unsuccessful diet and exercise?* | ||||
| Drug therapy for diabetes control | 4.3 | 4.1 | 4.1 | 4.5 |
| Drug therapy for dyslipidemia | 4.2 | 4.1 | 4.0 | 4.3 |
| Drug therapy for NASH | 3.1 | 3.1 | 2.8 | 3.2 |
| Drug therapy for weight loss | 2.8 | 2.8 | 2.4 | 3.9 |
| Bariatric surgery | 2.9 | 3.3 | 3.2 | 3.4 |
| Difference between initial recommendation and 12 months following unsuccessful lifestyle modifications | ||||
| Drug therapy for diabetes control | 0 | 0 | 0 | −0.1 |
| Drug therapy for dyslipidemia | 0 | 0 | 0 | −0.1 |
| Drug therapy for NASH | 0.5 | 0.3 | 0.4 | 0.3 |
| Drug therapy for weight loss | 0.5 | 0.4 | 0.4 | 0.5 |
| Bariatric surgery | 0.7 | 0.9 | 0.9 | 0.7 |
Notes: *Means of 1–5 scale: 1 = not at all likely, 5 = extremely likely. Respondents indicating “unsure/defer to another specialist” were removed from analysis.